Full Text View
Tabular View
No Study Results Posted
Related Studies
RDEA119 and Sorafenib Combination Dose Escalation Study
This study is currently recruiting participants.
Study NCT00785226   Information provided by Ardea Biosciences, Inc.
First Received: November 4, 2008   Last Updated: September 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Cancer
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
RDEA119 and Sorafenib
Additional drug interventions recognized in this trial
Sorafenib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Ardea Biosciences, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services